CRISPR Medicine News, 28 May 2020 | Opening the door to RNA editing therapies - CRISPR Medicine

Thank You for reading

RNA editing therapies on the horizon!

  • Decoding Guide RNA Rules for Cas13. Research from Neville Sanjana's lab at the New York Genome Center opens the door to RNA editing therapies that can influence gene expression without making permanent genetic changes. The group recently cracked the code on guide RNA design rules for the RNA-targeting endonuclease Cas13. This means that researchers can now, for the first time, knock down any RNA in the human genome!

  • Read more about Cas13 in our overview of CRISPR Cas endonucleases currently in focus for therapeutic applications.

Did you miss last weeks big news story?

  • The COVID19 diagnostic kit made history as the first FDA-approved CRISPR application.CEO Rahul Dhanda told us the inside story of how Sherlock Biosciences developed the kit.


More good reads


Thank You for now - more great reads are on the way.

And if you have questions or suggestions, you can directly reach us at We love hearing from readers!

(c; Rasmus

You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.